Nicox S.A. (OTCMKTS:NICXF) Sees Significant Decline in Short Interest

Nicox S.A. (OTCMKTS:NICXFGet Free Report) was the target of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 129,700 shares, a decrease of 18.2% from the September 30th total of 158,600 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Nicox Price Performance

Shares of OTCMKTS NICXF remained flat at $0.44 during midday trading on Wednesday. Nicox has a 52-week low of $0.44 and a 52-week high of $0.44. The firm has a 50-day moving average price of $0.44 and a two-hundred day moving average price of $0.44.

About Nicox

(Get Free Report)

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.

Featured Stories

Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.